HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A carbohydrate mimetic peptide modified size-shrinkable micelle nanocluster for anti-tumor targeting and penetrating drug delivery.

AbstractPURPOSE:
To deliver the chemotherapeutics through the nanoparticles, the delivery system should accumulate at the tumor site first and then penetrate through the interstitium into the interior. The specific tumor-targeting pathway mediated via the receptor-ligand binding could achieve the desirable accumulation of nanoparticles, and the nanoparticles with smaller sizes were required for penetration.
METHODS AND MATERIALS:
We constructed a size-shrinkable nanocluster modified with a tumor-targeting motif IF-7 (IF-7-MNC) based on a pH-sensitive framework which could be disintegrated in an acid environment to release the micelles aggregated inside. The micelles were constructed by amphiphilic block copolymers PEG-PLA to encapsulate paclitaxel (PTX), while the cross-linked framework consisting of TPGS-PEI was used as a net to gather and release micelles. This nanoplatform could specifically bind with the tumor receptor Annexin A1 through the ligand IF-7 and then shrunk into small micelles with a desirable size for penetration.
CONCLUSION:
IF-7-MNC of 112.27±6.81 nm could shrink into micelles in PBS (0.01 M, pH 5.0) with sizes of 14.89±0.32 nm. The cellular-uptake results showed that IF-7-MNC could be significantly internalized by A549 cells and HUVEC cells, while the penetration of IF-7-MNC could be more prominent into the 3D-tumor spheroids compared with that of MNC. The biodistribution results displayed that the fluorescence of IF-7-MNC in the tumor site at 24 hrs was 4.5-fold stronger than that of MNC. The results of anti-tumor growth demonstrated that IF-7-MNC was more favorable for the tumor therapy than MNC, where the inhibitory rate of tumor growth was 88.29% in the PTX-loaded IF-7-MNC (IF-7-PMNC) treated group, significantly greater than PMNC treatment group (p<0.05).
AuthorsQinyue Chen, Huihui Liang, Yali Sun, Yiting Chen, Wenxiu He, Xiaoling Fang, Xianyi Sha, Jinming Li
JournalInternational journal of nanomedicine (Int J Nanomedicine) Vol. 14 Pg. 7339-7352 ( 2019) ISSN: 1178-2013 [Electronic] New Zealand
PMID31686810 (Publication Type: Journal Article)
Copyright© 2019 Chen et al.
Chemical References
  • Antineoplastic Agents
  • Carbohydrates
  • Micelles
  • Peptides
  • monomethoxypolyethyleneglycol-polylactide block copolymer
  • Polyethylene Glycols
  • Paclitaxel
Topics
  • Animals
  • Antineoplastic Agents (pharmacology)
  • Carbohydrates (chemistry)
  • Cell Line, Tumor
  • Cell Survival (drug effects)
  • Drug Delivery Systems
  • Drug Liberation
  • Endocytosis
  • Humans
  • Hydrogen-Ion Concentration
  • Inhibitory Concentration 50
  • Male
  • Mice, Inbred BALB C
  • Mice, Nude
  • Micelles
  • Nanoparticles (chemistry, ultrastructure)
  • Neoplasms (drug therapy)
  • Paclitaxel (pharmacology, therapeutic use)
  • Particle Size
  • Peptides (chemistry)
  • Polyethylene Glycols
  • Spheroids, Cellular (drug effects, metabolism)
  • Static Electricity
  • Tissue Distribution

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: